Skip to content

For pharma CEO, a smaller pond, bigger waves

Before Maxine Gowen left the pharmaceutical giant GlaxoSmithKline in 2007, she was one of 103,000 employees in the company, and one of her jobs was to scout for small companies doing interesting research that might lead to new drugs and, perhaps, a corporate takeover.

Published